Increased inflammation, impaired bacterial clearance, and metabolic disruption after gram-negative sepsis in Mkp-1-deficient mice

J Immunol. 2009 Dec 1;183(11):7411-9. doi: 10.4049/jimmunol.0804343. Epub 2009 Nov 4.

Abstract

MAPKs are crucial for TNF-alpha and IL-6 production by innate immune cells in response to TLR ligands. MAPK phosphatase 1 (Mkp-1) deactivates p38 and JNK, abrogating the inflammatory response. We have previously demonstrated that Mkp-1(-/-) mice exhibit exacerbated inflammatory cytokine production and increased mortality in response to challenge with LPS and heat-killed Staphylococcus aureus. However, the function of Mkp-1 in host defense during live Gram-negative bacterial infection remains unclear. We challenged Mkp-1(+/+) and Mkp-1(-/-) mice with live Escherichia coli i.v. to examine the effects of Mkp-1 deficiency on animal survival, bacterial clearance, metabolic activity, and cytokine production. We found that Mkp-1 deficiency predisposed animals to accelerated mortality and was associated with more robust production of TNF-alpha, IL-6 and IL-10, greater bacterial burden, altered cyclooxygenase-2 and iNOS expression, and substantial changes in the mobilization of energy stores. Likewise, knockout of Mkp-1 also sensitized mice to sepsis caused by cecal ligation and puncture. IL-10 inhibition by neutralizing Ab or genetic deletion alleviated increased bacterial burden. Treatment with the bactericidal antibiotic gentamicin, given 3 h after Escherichia coli infection, protected Mkp-1(+/+) mice from septic shock but had no effect on Mkp-1(-/-) mice. Thus, during Gram-negative bacterial sepsis Mkp-1 not only plays a critical role in the regulation of cytokine production but also orchestrates the bactericidal activities of the innate immune system and controls the metabolic response to stress.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cyclooxygenase 2 / biosynthesis
  • Cyclooxygenase 2 / immunology
  • Dual Specificity Phosphatase 1 / deficiency
  • Dual Specificity Phosphatase 1 / immunology*
  • Enzyme-Linked Immunosorbent Assay
  • Escherichia coli
  • Escherichia coli Infections / immunology*
  • Escherichia coli Infections / metabolism*
  • Glucose / metabolism
  • Glycogen / metabolism
  • Gram-Negative Bacterial Infections / immunology
  • Gram-Negative Bacterial Infections / metabolism
  • Hyperlipidemias / metabolism
  • Hyperlipidemias / microbiology
  • Inflammation / immunology*
  • Inflammation / metabolism
  • Inflammation / microbiology
  • Interleukin-10 / biosynthesis
  • Interleukin-10 / immunology
  • Interleukin-6 / biosynthesis
  • Interleukin-6 / immunology
  • Lipid Metabolism / immunology
  • Mice
  • Mice, Knockout
  • Nitric Oxide Synthase Type II / biosynthesis
  • Nitric Oxide Synthase Type II / immunology
  • Sepsis / immunology*
  • Sepsis / microbiology
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Glycogen
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
  • Dual Specificity Phosphatase 1
  • Dusp1 protein, mouse
  • Glucose